Clinical trial
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With…
NCT00007826 · Onyvax, Industry · Unknown status
Key facts
| NCT number | NCT00007826 |
|---|---|
| Title | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer |
| Official title | A Phase I/II Trial of an Allogeneic Cell Based Vaccine and an Anti-Idiotypic Antibody Vaccine Approach for Metastatic Adenocarcinoma of the Colon or Rectum |
| Lead sponsor | Onyvax, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | BCG vaccine, monoclonal antibody 105AD7 anti-idiotype vaccine, alum adjuvant |
| Start date | Apr 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: